Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-11-10Clinical Trial Update: Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder [NA]
A randomized, double-blind trial evaluating Jia Wei Xiao Yao Jiaonang for mild to moderate major depressive disorder.
-
FDA approval · 2011-11-09FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) from H2-Pharma, LLC.
-
FDA approval · 2011-11-09FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA has approved a supplemental application for SEROQUEL XR (quetiapine) by AstraZeneca Pharmaceuticals LP. The approval pertains to mod…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder [Phase 4]
Phase 4 clinical trial evaluating duloxetine in patients with diabetic peripheral neuropathic pain with or without comorbid major depressive…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Monoamine Transporter Function and Autonomic Regulation During Psychodynamic Psychotherapy
This completed clinical trial evaluated monoamine transporter function and autonomic regulation during psychodynamic psychotherapy in indivi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder [NA]
This update summarizes factors associated with antidepressant treatment response in patients with Major Depressive Disorder from a completed…
-
CLINICAL_TRIALS trial_result · 2011-10-25Clinical Trial Update: Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.
A completed clinical trial indicates that certain personality types may predict the onset of depression and decreased quality of life in str…
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety [Phase 2]
The document notes the completion of a Phase 2 safety and effectiveness trial comparing BCI-540 to placebo for major depressive disorder wit…
-
CLINICAL_TRIALS trial_result · 2011-10-18Clinical Trial Update: Teen Depression Awareness Project (TDAP) [Phase 1]
This Phase 1 trial conducted by RAND evaluating the Teen Depression Awareness Project (TDAP) for depression has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-18Clinical Trial Update: Cognitive Control Training for Depression [NA]
The clinical trial evaluating cognitive control training for depression has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) [Phase 4]
Phase 4 pediatric post-marketing study of Paxil (paroxetine) for depression in Japan was terminated; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial [Phase 4]
A Phase 4 randomized trial assessing whether adding folic acid to standard depression treatment improves outcomes; the study is completed.
-
CLINICAL_TRIALS research · 2011-10-05Clinical Trial Update: Suicidal Ideation and Behavior in Korean Adolescents With Depression
An update on a clinical trial examining suicidal ideation and behavior in Korean adolescents with depression; the study status is currently …
-
CLINICAL_TRIALS trial_result · 2011-10-03Clinical Trial Update: A Study of Patients With Major Depressive Disorder and Residual Apathy [Phase 4]
Phase 4 trial update in patients with Major Depressive Disorder and residual apathy completed; results were posted in 2011.
-
FDA label_change · 2011-09-21FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) from Allergan, Inc., updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Beyond Ageing Project: A Study for the Prevention of Depression [Phase 2]
This Phase 2 clinical trial from the Australian National University, focused on preventing depression, has completed. The study explored pre…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: PHARMO Institute Seroquel Safety Study
A completed PHARMO Institute safety study evaluating Seroquel (quetiapine) across schizophrenia, major depressive disorder, bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Telemedicine-Based Collaborative Care to Reduce Rural Disparities [NA]
This clinical trial update reports on a telemedicine-based collaborative care model to address depression in rural populations; the study is…
-
CLINICAL_TRIALS withdrawal · 2011-08-30Clinical Trial Update: Hormonal Levels in Men With Major Depressive Disorder
A clinical trial investigating hormonal levels in men with major depressive disorder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD [Phase 1, Phase 2]
An update on the completed Phase 1/2 safety and tolerability study of ALKS 5461 (ALKS 33-BUP) in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Survey of Adolescent Living in Vestmanland
A completed study by Uppsala University surveyed adolescents in Vestmanland, focusing on alcohol use disorders and depression and noting beh…
-
FDA approval · 2011-08-19FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (Mylan Pharmaceuticals Inc.), indicating regulatory action on this gene…
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: PACEPro - Mood Management Pilot [NA]
The PACEPro mood management pilot trial for depression has completed.
-
CLINICAL_TRIALS withdrawal · 2011-08-16Clinical Trial Update: Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease [Phase 4]
The Phase 4 open-label trial of fluoxetine for treating depression in patients with end-stage renal disease has been withdrawn.
-
CLINICAL_TRIALS research · 2011-08-15Clinical Trial Update: Treatment of Depression in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial is evaluating treatment for depression in Parkinson's disease. The current status is unknown.